Table 3 Univariate and multivariate logistic regression analysis evaluated risk factors predicting hypovitaminosis D
From: Hypovitaminosis D and risk factors in pediatric epilepsy children
Factor | Univariate model | Multivariate model | ||||
|---|---|---|---|---|---|---|
Crude Odds Ratio | 95%CI | p-value | Adjusted Odds Ratio | 95%CI | p-value | |
Gender | ||||||
male | 1 | 1 | ||||
female | 1.935 | 0.904-4.14 | 0.089 | 1.568 | 0.649-3.786 | 0.318 |
Puberty status | ||||||
prepuberty | 1 | 1 | ||||
puberty | 4.911 | 1.983-12.159 | 0.001* | 5.426 | 1.879-15.67 | 0.002* |
Duration of sun exposed, during 10 am-14 pm | ||||||
< 60 min/day | 3.357 | 0.852-13.223 | 0.083 | 2.68 | 0.455-15.79 | 0.276 |
≥ 60 min/day | 1 | 1 | ||||
Monotherapy | ||||||
No | 1 | 1 | ||||
Yes | 1.628 | 0.772-3.434 | 0.201 | 1.49 | 0.442-5.028 | 0.520 |
Enzyme-inducer ASMs (CBZ,PB,PHT) | ||||||
No | 1 | 1 | ||||
Yes | 1.453 | 0.536-3.939 | 0.463 | 1.306 | 0.372-4.582 | 0.677 |
Enzyme-inhibitor ASMs (VPA) | ||||||
No | 1.97 | 0.932-4.162 | 0.074 | 3.578 | 1.117-11.46 | 0.032* |
Yes | 1 | 1 | ||||
BZD and Newer ASMs | ||||||
No | 1.363 | 0.500-3.712 | 0.545 | 2.029 | 0.376-10.941 | 0.411 |
Yes | 1 | 1 | ||||
Duration of ASMs used | ||||||
≤ 2 years | 1 | 1 | ||||
> 2 years | 2.667 | 1.175-6.05 | 0.019* | 2.222 | 0.827-5.969 | 0.113 |